196 related articles for article (PubMed ID: 9382047)
1. Significance of serum immunoglobulin M to hepatitis C virus core in patients with chronic hepatitis C.
Tran A; Yang G; Dreyfus G; Rouquié P; Durant J; Rampal A; Rampal P; Benzaken S
Am J Gastroenterol; 1997 Oct; 92(10):1835-8. PubMed ID: 9382047
[TBL] [Abstract][Full Text] [Related]
2. The significance of immunoglobulin M antibody response to hepatitis C virus core protein in patients with chronic hepatitis C.
Yuki N; Hayashi N; Ohkawa K; Hagiwara H; Oshita M; Katayama K; Sasaki Y; Kasahara A; Fusamoto H; Kamada T
Hepatology; 1995 Aug; 22(2):402-6. PubMed ID: 7543432
[TBL] [Abstract][Full Text] [Related]
3. Immunoglobulin M antibody to hepatitis C virus core antigen: correlations with viral replication, histological activity, and liver disease outcome.
Quiroga JA; van Binsbergen J; Wang CY; Pardo M; Navas S; Trines C; Herrero M; Carreño V
Hepatology; 1995 Dec; 22(6):1635-40. PubMed ID: 7489967
[TBL] [Abstract][Full Text] [Related]
4. Sequential changes of hepatitis C virus antibody profiles during treatment of chronic hepatitis C of genotype 1b: pretreatment antibody response to E2/NS1 correlated sustained response.
Chu CM; Sheen IS; Liaw YF
Infection; 2004 Jun; 32(3):153-6. PubMed ID: 15188075
[TBL] [Abstract][Full Text] [Related]
5. [Serologic response against hepatitis C virus as a predictive factor to the treatment with interferon].
Garrido A; Lepe JA; Guerrero FJ; Palomo S
Enferm Infecc Microbiol Clin; 2000 Dec; 18(10):512-5. PubMed ID: 11198002
[TBL] [Abstract][Full Text] [Related]
6. Studies of the effectiveness of interferon alpha treatment for chronic hepatitis C in children.
Czerwionka-Szaflarska M; Chrobot A; Szaflarska-Szczepanik A
Med Sci Monit; 2000; 6(5):964-70. PubMed ID: 11208439
[TBL] [Abstract][Full Text] [Related]
7. IgM anti-hepatitis C virus core antibodies as marker of recurrent hepatitis C after liver transplantation.
Negro F; Giostra E; Rubbia-Brandt L; Mentha G; Colucci G; Morel P; Quadri R; Perrin L; Hadengue A
J Med Virol; 1998 Nov; 56(3):224-9. PubMed ID: 9783689
[TBL] [Abstract][Full Text] [Related]
8. Interferon therapy in HCV-positive mixed cryoglobulinaemia: viral and host factors contributing to efficacy of the therapy.
Mazzaro C; Carniello GS; Colle R; Doretto P; Mazzi G; Crovatto M; Santini GF; Tulissi P; Gregoretti M; Mazzoran L; Russo A; Silvestri F; Pozzato G
Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):343-50. PubMed ID: 9476189
[TBL] [Abstract][Full Text] [Related]
9. Clinical importance of assessment of anti-HCV IgM antibodies in chronic hepatitis C.
Stránský J; Honzáková E; Vandasová J; Horejsová M; Kyncl J; Nĕmecek V; Horák J
Acta Virol; 1996 Apr; 40(2):61-5. PubMed ID: 8886113
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C virus recurrence after liver transplantation: relationship to anti-HCV core IgM, genotype, and level of viremia.
Crespo J; Carte B; Lozano JL; Casafont F; Rivero M; de la Cruz F; Pons-Romero F
Am J Gastroenterol; 1997 Sep; 92(9):1458-62. PubMed ID: 9317062
[TBL] [Abstract][Full Text] [Related]
11. [Evaluation of specific humoral response to hepatitis C core antigen in children].
Kupś J; Woźniakowska-Gesicka T
Przegl Lek; 2003; 60(12):802-5. PubMed ID: 15058020
[TBL] [Abstract][Full Text] [Related]
12. Changes in hepatitis C virus (HCV) antibody status in patients with chronic hepatitis C after eradication of HCV infection by interferon therapy.
Toyoda H; Kumada T; Kiriyama S; Sone Y; Tanikawa M; Hisanaga Y; Kuzuya T; Honda T; Hayashi K; Nakano I; Katano Y; Goto H
Clin Infect Dis; 2005 Mar; 40(6):e49-54. PubMed ID: 15736006
[TBL] [Abstract][Full Text] [Related]
13. Genetic complexity of the hypervariable region 1 (HVR1) of hepatitis C virus (HCV): influence on the characteristics of the infection and responses to interferon alfa therapy in patients with chronic hepatitis C.
Pawlotsky JM; Pellerin M; Bouvier M; Roudot-Thoraval F; Germanidis G; Bastie A; Darthuy F; Rémiré J; Soussy CJ; Dhumeaux D
J Med Virol; 1998 Apr; 54(4):256-64. PubMed ID: 9557291
[TBL] [Abstract][Full Text] [Related]
14. Pilot study on the safety and efficacy of intravenous natural beta-interferon therapy in patients with chronic hepatitis C unresponsive to alpha-interferon.
Mazzoran L; Grassi G; Giacca M; Gerini U; Baracetti S; Fanni-Canelles M; Zorat F; Pozzato G
Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):338-42. PubMed ID: 9476188
[TBL] [Abstract][Full Text] [Related]
15. Interferon therapy in hemodialysis patients with chronic hepatitis C virus infection induces a high rate of long-term sustained virological and biochemical response.
Espinosa M; Rodriguez M; Martin-Malo A; Alvarez de Lara MA; Gonzalez R; Lopez-Rubio F; de la Mata M; Aljama P
Clin Nephrol; 2001 Mar; 55(3):220-6. PubMed ID: 11316242
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of molecular parameters for routine assessment of viremia in patients with chronic hepatitis C who are undergoing antiviral therapy.
Kessler HH; Pierer K; Santner BI; Vellimedu SK; Stelzl E; Marth E; Fickert P; Stauber RE
J Hum Virol; 1998; 1(5):314-9. PubMed ID: 10195258
[TBL] [Abstract][Full Text] [Related]
17. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N
Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715
[TBL] [Abstract][Full Text] [Related]
18. Types of human leukocyte antigen and decrease in HCV core antigen in serum for predicting efficacy of interferon-Alpha in patients with chronic hepatitis C: analysis by a prospective study.
Muto H; Tanaka E; Matsumoto A; Yoshizawa K; Kiyosawa K;
J Gastroenterol; 2004 Jul; 39(7):674-80. PubMed ID: 15293139
[TBL] [Abstract][Full Text] [Related]
19. Modulation of epitope-specific anti-hepatitis C virus E2 (anti-HCV/E2) antibodies by anti-viral treatment.
Mancini N; Carletti S; Perotti M; Romanò L; Craxì RD; Craxì A; Zanetti AR; Clementi M; Burioni R
J Med Virol; 2006 Oct; 78(10):1304-11. PubMed ID: 16927283
[TBL] [Abstract][Full Text] [Related]
20. Significance of anti-hepatitis C virus core IgM antibodies in patients with chronic hepatitis C.
Pawlotsky JM; Darthuy F; Rémiré J; Pellet C; Udin L; Stuyver L; Roudot-Thoraval F; Duvoux C; Douvin C; Mallat A
J Med Virol; 1995 Nov; 47(3):285-91. PubMed ID: 8551282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
